Table of Contents Author Guidelines Submit a Manuscript
International Journal of Cell Biology
Volume 2012, Article ID 607929, 6 pages
http://dx.doi.org/10.1155/2012/607929
Review Article

Mitochondrial Stress Signalling: HTRA2 and Parkinson's Disease

1Department of Biology, University of Rome “Tor Vergata”, 00133 Rome, Italy
2Cell Death Regulation Laboratory, MRC Toxicology Unit, Hodgkin Building, Lancaster Road, Leicester LE1 9HN, UK

Received 31 January 2012; Accepted 13 March 2012

Academic Editor: Pier Giorgio Mastroberardino

Copyright © 2012 Enrico Desideri and L. Miguel Martins. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. W. Gray, G. Burger, and B. F. Lang, “Mitochondrial evolution,” Science, vol. 283, no. 5407, pp. 1476–1481, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Finkel, “Signal transduction by mitochondrial oxidants,” The Journal of Biological Chemistry, vol. 287, no. 7, pp. 4434–4440, 2012. View at Publisher · View at Google Scholar
  3. I. P. De Castro, L. M. Martins, and S. H. Y. Loh, “Mitochondrial quality control and Parkinson's disease: a pathway unfolds,” Molecular Neurobiology, vol. 43, no. 2, pp. 80–86, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. M. F. Beal, “Parkinson's disease: a model dilemma,” Nature, vol. 466, pp. S8–S10, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. E. M. Valente, P. M. Abou-Sleiman, V. Caputo et al., “Hereditary early-onset Parkinson's disease caused by mutations in PINK1,” Science, vol. 304, no. 5674, pp. 1158–1160, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. K. M. Strauss, L. M. Martins, H. Plun-Favreau et al., “Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease,” Human Molecular Genetics, vol. 14, no. 15, pp. 2099–2111, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Krüger, M. Sharma, O. Riess et al., “A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's disease,” Neurobiology of Aging, vol. 32, no. 3, pp. 548.e9–548.e18, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Tretter and V. Adam-Vizi, “Generation of reactive oxygen species in the reaction catalyzed by α-ketoglutarate dehydrogenase,” Journal of Neuroscience, vol. 24, no. 36, pp. 7771–7778, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. A. A. Starkov, G. Fiskum, C. Chinopoulos et al., “Mitochondrial α-ketoglutarate dehydrogenase complex generates reactive oxygen species,” Journal of Neuroscience, vol. 24, no. 36, pp. 7779–7788, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. A. G. Cox, C. C. Winterbourn, and M. B. Hampton, “Mitochondrial peroxiredoxin involvement in antioxidant defence and redox signalling,” Biochemical Journal, vol. 425, no. 2, pp. 313–325, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. E. A. Veal, A. M. Day, and B. A. Morgan, “Hydrogen peroxide sensing and signaling,” Molecular Cell, vol. 26, no. 1, pp. 1–14, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Fujino, T. Noguchi, K. Takeda, and H. Ichijo, “Thioredoxin and protein kinases in redox signaling,” Seminars in Cancer Biology, vol. 16, no. 6, pp. 427–435, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Saitoh, H. Nishitoh, M. Fujii et al., “Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1,” The EMBO Journal, vol. 17, no. 9, pp. 2596–2606, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Liu, H. Nishitoh, H. Ichijo, and J. M. Kyriakis, “Activation of apoptosis signal-regulating kinase 1 (ASK1) by tumor necrosis factor receptor-associated factor 2 requires prior dissociation of the ASK1 inhibitor thioredoxin,” Molecular and Cellular Biology, vol. 20, no. 6, pp. 2198–2208, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Kamata, S. I. Honda, S. Maeda, L. Chang, H. Hirata, and M. Karin, “Reactive oxygen species promote TNFα-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases,” Cell, vol. 120, no. 5, pp. 649–661, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. M. J. Robinson and M. H. Cobb, “Mitogen-activated protein kinase pathways,” Current Opinion in Cell Biology, vol. 9, no. 2, pp. 180–186, 1997. View at Publisher · View at Google Scholar · View at Scopus
  17. J. M. Kyriakis and J. Avruch, “Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation,” Physiological Reviews, vol. 81, no. 2, pp. 807–869, 2001. View at Google Scholar · View at Scopus
  18. C. H. Lin, M. L. Chen, G. S. Chen, C. H. Tai, and R. M. Wu, “Novel variant Pro143Ala in HTRA2 contributes to Parkinson's disease by inducing hyperphosphorylation of HTRA2 protein in mitochondria,” Human Genetics, vol. 130, no. 6, pp. 817–827, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. V. Bogaerts, K. Nuytemans, J. Reumers et al., “Genetic variability in the mitochondrial serine protease HTRA2 contributes to risk for Parkinson disease,” Human Mutation, vol. 29, no. 6, pp. 832–840, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Plun-Favreau, K. Klupsch, N. Moisoi et al., “The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1,” Nature Cell Biology, vol. 9, no. 11, pp. 1243–1252, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. J. C. Fitzgerald, M. D. Camprubi, L. Dunn et al., “Phosphorylation of HtrA2 by cyclin-dependent kinase-5 is important for mitochondrial function,” Cell Death & Differentiation, vol. 19, pp. 257–266, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. I. P. De Castro, L. M. Martins, and R. Tufi, “Mitochondrial quality control and neurological disease: an emerging connection,” Expert Reviews in Molecular Medicine, vol. 12, article e12, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Tatsuta and T. Langer, “Quality control of mitochondria: protection against neurodegeneration and ageing,” The EMBO Journal, vol. 27, no. 2, pp. 306–314, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. N. Moisoi, K. Klupsch, V. Fedele et al., “Mitochondrial dysfunction triggered by loss of HtrA2 results in the activation of a brain-specific transcriptional stress response,” Cell Death & Differentiation, vol. 16, no. 3, pp. 449–464, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. I. P. De Castro, A. C. Costa, and D. Lam, “Genetic analysis of mitochondrial protein misfolding in Drosophila melanogaster,” Cell Death & Differentiation. In press. View at Publisher · View at Google Scholar
  26. G. Twig, A. Elorza, A. J. A. Molina et al., “Fission and selective fusion govern mitochondrial segregation and elimination by autophagy,” The EMBO Journal, vol. 27, no. 2, pp. 433–446, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. D. Narendra, A. Tanaka, D. F. Suen, and R. J. Youle, “Parkin is recruited selectively to impaired mitochondria and promotes their autophagy,” Journal of Cell Biology, vol. 183, no. 5, pp. 795–803, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. R. J. Youle and A. Strasser, “The BCL-2 protein family: opposing activities that mediate cell death,” Nature Reviews Molecular Cell Biology, vol. 9, no. 1, pp. 47–59, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. L. M. Martins, I. Iaccarino, T. Tenev et al., “The serine protease Omi/HtrA2 regulates apoptosis by binding XIAP through a Reaper-like motif,” Journal of Biological Chemistry, vol. 277, no. 1, pp. 439–444, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. Suzuki, Y. Imai, H. Nakayama, K. Takahashi, K. Takio, and R. Takahashi, “A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death,” Molecular Cell, vol. 8, no. 3, pp. 613–621, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. R. Hegde, S. M. Srinivasula, Z. Zhang et al., “Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction,” Journal of Biological Chemistry, vol. 277, no. 1, pp. 432–438, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. A. M. Verhagen, J. Silke, P. G. Ekert et al., “HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins,” Journal of Biological Chemistry, vol. 277, no. 1, pp. 445–454, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. L. M. Martins, A. Morrison, K. Klupsch et al., “Neuroprotective role of the reaper-related serine protease HtrA2/Omi revealed by targeted deletion in mice,” Molecular and Cellular Biology, vol. 24, no. 22, pp. 9848–9862, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. J. M. Jones, P. Datta, S. M. Srinivasula et al., “Loss of Omi mitochondrial protease activity causes the neuromuscular disorder of mnd2 mutant mice,” Nature, vol. 425, no. 6959, pp. 721–727, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. N. Ruiz, D. Kahne, and T. J. Silhavy, “Advances in understanding bacterial outer-membrane biogenesis,” Nature Reviews Microbiology, vol. 4, no. 1, pp. 57–66, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. T. Clausen, M. Kaiser, R. Huber, and M. Ehrmann, “HTRA proteases: regulated proteolysis in protein quality control,” Nature Reviews Molecular Cell Biology, vol. 12, no. 3, pp. 152–162, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. L. M. Martins, B. E. Turk, V. Cowling et al., “Binding specificity and regulation of the serine protease and PDZ domains of HtrA2/Omi.,” The Journal of biological chemistry, vol. 278, no. 49, pp. 49417–49427, 2003. View at Google Scholar · View at Scopus
  38. R. Dhavan and L. H. Tsai, “A decade of CDK5,” Nature Reviews Molecular Cell Biology, vol. 2, no. 10, pp. 749–759, 2001. View at Publisher · View at Google Scholar · View at Scopus
  39. T. Ohshima, J. M. Ward, C. G. Huh et al., “Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 20, pp. 11173–11178, 1996. View at Publisher · View at Google Scholar · View at Scopus